Myeongmun Pharmaceutical Reports Operating Profit of 2.4 Billion KRW Last Year, Down 63.3% YoY

Myeongmun Pharmaceutical announced on the 20th that its operating profit on a consolidated basis last year was 2,361.87 million KRW, a decrease of 63.3% compared to the previous year. Sales revenue was recorded at 170,541.99 million KRW, an increase of 12.1%.